Business Wire

The Open Group October Virtual Event To Celebrate 25 Years of Open Technology Standards

19.10.2021 11:00:00 EEST | Business Wire | Press release

Share

The Open Group, the vendor-neutral technology standards consortium, is hosting its upcoming “Open Digital Standards” event October 25 – 27, 2021.

The Open Digital Standards event will bring together vendors and end-user organizations from across the globe to discuss how the cross-industry development of open standards is helping businesses become digital-first.

The virtual event will start at 11:30 am Shanghai local time on Tuesday October 26 (8:30 pm PDT October 25), and finish at 1:30 pm local time in Boston on Wednesday October 27. Regional sessions will be hosted in their local languages by all The Open Group offices throughout the globe – Shanghai, Mumbai, London, Sao Paulo, San Francisco, Tokyo, Johannesburg, Boston.

Presentations on Tuesday will focus on the work of The TOGAF® Standard and impact of the UNIX® Standard. Throughout the day, speakers from organizations such as Chevron, NGINX Inc., Capgemini Insights & Data, and National Air Traffic Services, will join TOGAF® Standard Product Manager Sonia Gonzales and Chair of The Open Group ArchiMate® Forum Jean-Baptiste Sarrodie to explore the changing role of Enterprise Architects (EA) and the evolution and impact of ArchiMate®. Presentations will provide practical examples of how these standards are being applied within a range of industries to improve business efficiency.

On Wednesday, attendees will have the opportunity to hear from The Open Group CDO Dave Lounsbury and Micro Focus CTO Dr. Lars Rossen about open standards for the digital enterprise and agile world. Sessions in the afternoon will feature speakers from L3Harris and Lockheed Martin and explore the implications of open technical standards applicable to military and commercial sensor systems including the FACE™ Consortium and SOSA™ Consortium and the recent launch of the Technical Standard for SOSA™ Reference Architecture, Edition 1.0.

Continuing on in the afternoon, Dr. Jack Freund, Head of Cyber Risk Methodology at VisibleRisk, will discuss the value of risk analysis and provide practical guidance on the Open FAIR™ approach, a model and taxonomy for understanding, analyzing, and measuring information risk.

Key speakers at the event include:

  • Steve Nunn, President & CEO, The Open Group
  • James de Raeve, Vice President, The Open Group
  • Junkyo (Jack) Fujieda, Representative and Chairman, The Open Group Japan
  • Dr. Pallab Saha, General Manager, The Open Group India
  • Stuart Macgregor, Chief Executive, The Open Group South Africa and Real IRM Solutions
  • Roberto Severo, Country Manager, The Open Group Brazil
  • Andras Szakal, CTO, The Open Group
  • Hiroki Habuka, Deputy Director for Global Digital Governance, Ministry of Economy, Trade and Industry, Japan (METI)
  • Regine Deleu, General Manager (Digital Architecture), Auckland Transport, Govt of New Zealand
  • Patrick Kelly, Product Leader, Chevron
  • Kartik Ravel, Senior Director, Digital Transformation Services, Fujitsu
  • Dr. Che Haiping, Senior Vice President, Chief Digital Transformation Officer, Huawei Technologies

Additional key topics of discussion include:

  • The Role of Standards in a Data Economy – On Tuesday, J. Satyanarayana, Chief Advisor, C4IR India, World Economic Forum Member, Advisory Board, Global Forum on Cyber Expertise (GFCE), Netherlands, will discuss how the use of standards spanning the entire data lifecycle becomes a strategic imperative to accelerate the transition to a data and a digital economy
  • Standards in Action: TOGAF, Open FAIR, Open Agile Architecture – On Tuesday, Peter Haviland, Chief Information and Operating Officer, Angle Finance, will recount some hits and misses over the past 15 years contributing to and using The Open Group standards
  • Product Integrity and Global Supply Chain Security – On Wednesday, Joanne Woytek, NASA SEWP Program Director, will provide a synopsis of key factors in Supply Chain Risk Management for Acquisition of IT solutions by the US Government with applicability to similar Global market acquisition activities
  • A Data-Driven Approach to Environmental Footprint and Sustainability: How Open Footprint impacts GHG Alignment – In various regional sessions, a panel of Open Footprint™ Forum (OFP) experts will discuss why there is a business imperative to address the challenges and current gaps additionally with an overview of what are the global and local challenges followed by what OFP is aiming to address

Agenda and registration details can be found here.

-ENDS-

About The Open Group

The Open Group is a global consortium that enables the achievement of business objectives through technology standards. Our diverse membership of more than 850 organizations includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. Further information on The Open Group can be found at www.opengroup.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Meghan Marks
Senior Programme Manager, Hotwire
UKOpengroup@hotwirepr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye